Lead extraction outcomes in patients with congenital heart disease

Erin A. Fender, Ammar M. Killu, Bryan C. Cannon, Paul Andrew Friedman, Christopher J. Mcleod, David O. Hodge, Craig S. Broberg, Charles A. Henrikson, Yong-Mei Cha

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Aims: Patients with congenital heart disease (CHD) are at increased risk for intracardiac device malfunction and infection that may necessitate extraction; however, the risk of extraction is poorly understood. This study addresses the safety of extraction in patients with structural heart disease and previous cardiac surgery. Methods and results: This retrospective study included 40 CHD and 80 matched control patients, who underwent transvenous lead extractions between 2001 and 2014. Only leads >12 months were included. There were 77 leads in CHD patients and 146 in controls. The mean age was 38 ± 16 years in CHD patients. Ninety per cent of CHD patients had ≥1 cardiac surgeries when compared with 21% of controls (P < 0.001). The number of abandoned leads was significantly different (17 vs. 3, P < 0.001). Lead age was similar with an average duration of 83 ± 87 months in CHD patients and 62 ± 65 months in controls (P = 0.24). There was no significant difference in extraction techniques. Manual traction was successful in 40% of CHD patients and 47% of controls, and advanced techniques were used in 60 and 53% of CHD patients and controls, respectively. Complete extraction was achieved in 94% of the patients in both groups. There was no significant difference in complications. Conclusion: Lead extraction can be safely performed in patients with CHD. Despite anatomic abnormalities and longer implantation times, the difficulty of lead extraction in patients with CHD is comparable with controls.

Original languageEnglish (US)
Pages (from-to)441-446
Number of pages6
JournalEuropace
Volume19
Issue number3
DOIs
StatePublished - 2017

Fingerprint

Heart Diseases
Thoracic Surgery
Lead
Traction
Retrospective Studies
Safety
Equipment and Supplies
Infection

Keywords

  • Cardiac implantable electronic device
  • Congenital heart disease
  • Laser lead extraction
  • Lead extraction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Fender, E. A., Killu, A. M., Cannon, B. C., Friedman, P. A., Mcleod, C. J., Hodge, D. O., ... Cha, Y-M. (2017). Lead extraction outcomes in patients with congenital heart disease. Europace, 19(3), 441-446. https://doi.org/10.1093/europace/euw049

Lead extraction outcomes in patients with congenital heart disease. / Fender, Erin A.; Killu, Ammar M.; Cannon, Bryan C.; Friedman, Paul Andrew; Mcleod, Christopher J.; Hodge, David O.; Broberg, Craig S.; Henrikson, Charles A.; Cha, Yong-Mei.

In: Europace, Vol. 19, No. 3, 2017, p. 441-446.

Research output: Contribution to journalArticle

Fender, EA, Killu, AM, Cannon, BC, Friedman, PA, Mcleod, CJ, Hodge, DO, Broberg, CS, Henrikson, CA & Cha, Y-M 2017, 'Lead extraction outcomes in patients with congenital heart disease', Europace, vol. 19, no. 3, pp. 441-446. https://doi.org/10.1093/europace/euw049
Fender, Erin A. ; Killu, Ammar M. ; Cannon, Bryan C. ; Friedman, Paul Andrew ; Mcleod, Christopher J. ; Hodge, David O. ; Broberg, Craig S. ; Henrikson, Charles A. ; Cha, Yong-Mei. / Lead extraction outcomes in patients with congenital heart disease. In: Europace. 2017 ; Vol. 19, No. 3. pp. 441-446.
@article{3f45f6e930da4e1c8042a7ad264d2845,
title = "Lead extraction outcomes in patients with congenital heart disease",
abstract = "Aims: Patients with congenital heart disease (CHD) are at increased risk for intracardiac device malfunction and infection that may necessitate extraction; however, the risk of extraction is poorly understood. This study addresses the safety of extraction in patients with structural heart disease and previous cardiac surgery. Methods and results: This retrospective study included 40 CHD and 80 matched control patients, who underwent transvenous lead extractions between 2001 and 2014. Only leads >12 months were included. There were 77 leads in CHD patients and 146 in controls. The mean age was 38 ± 16 years in CHD patients. Ninety per cent of CHD patients had ≥1 cardiac surgeries when compared with 21{\%} of controls (P < 0.001). The number of abandoned leads was significantly different (17 vs. 3, P < 0.001). Lead age was similar with an average duration of 83 ± 87 months in CHD patients and 62 ± 65 months in controls (P = 0.24). There was no significant difference in extraction techniques. Manual traction was successful in 40{\%} of CHD patients and 47{\%} of controls, and advanced techniques were used in 60 and 53{\%} of CHD patients and controls, respectively. Complete extraction was achieved in 94{\%} of the patients in both groups. There was no significant difference in complications. Conclusion: Lead extraction can be safely performed in patients with CHD. Despite anatomic abnormalities and longer implantation times, the difficulty of lead extraction in patients with CHD is comparable with controls.",
keywords = "Cardiac implantable electronic device, Congenital heart disease, Laser lead extraction, Lead extraction",
author = "Fender, {Erin A.} and Killu, {Ammar M.} and Cannon, {Bryan C.} and Friedman, {Paul Andrew} and Mcleod, {Christopher J.} and Hodge, {David O.} and Broberg, {Craig S.} and Henrikson, {Charles A.} and Yong-Mei Cha",
year = "2017",
doi = "10.1093/europace/euw049",
language = "English (US)",
volume = "19",
pages = "441--446",
journal = "Europace",
issn = "1099-5129",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Lead extraction outcomes in patients with congenital heart disease

AU - Fender, Erin A.

AU - Killu, Ammar M.

AU - Cannon, Bryan C.

AU - Friedman, Paul Andrew

AU - Mcleod, Christopher J.

AU - Hodge, David O.

AU - Broberg, Craig S.

AU - Henrikson, Charles A.

AU - Cha, Yong-Mei

PY - 2017

Y1 - 2017

N2 - Aims: Patients with congenital heart disease (CHD) are at increased risk for intracardiac device malfunction and infection that may necessitate extraction; however, the risk of extraction is poorly understood. This study addresses the safety of extraction in patients with structural heart disease and previous cardiac surgery. Methods and results: This retrospective study included 40 CHD and 80 matched control patients, who underwent transvenous lead extractions between 2001 and 2014. Only leads >12 months were included. There were 77 leads in CHD patients and 146 in controls. The mean age was 38 ± 16 years in CHD patients. Ninety per cent of CHD patients had ≥1 cardiac surgeries when compared with 21% of controls (P < 0.001). The number of abandoned leads was significantly different (17 vs. 3, P < 0.001). Lead age was similar with an average duration of 83 ± 87 months in CHD patients and 62 ± 65 months in controls (P = 0.24). There was no significant difference in extraction techniques. Manual traction was successful in 40% of CHD patients and 47% of controls, and advanced techniques were used in 60 and 53% of CHD patients and controls, respectively. Complete extraction was achieved in 94% of the patients in both groups. There was no significant difference in complications. Conclusion: Lead extraction can be safely performed in patients with CHD. Despite anatomic abnormalities and longer implantation times, the difficulty of lead extraction in patients with CHD is comparable with controls.

AB - Aims: Patients with congenital heart disease (CHD) are at increased risk for intracardiac device malfunction and infection that may necessitate extraction; however, the risk of extraction is poorly understood. This study addresses the safety of extraction in patients with structural heart disease and previous cardiac surgery. Methods and results: This retrospective study included 40 CHD and 80 matched control patients, who underwent transvenous lead extractions between 2001 and 2014. Only leads >12 months were included. There were 77 leads in CHD patients and 146 in controls. The mean age was 38 ± 16 years in CHD patients. Ninety per cent of CHD patients had ≥1 cardiac surgeries when compared with 21% of controls (P < 0.001). The number of abandoned leads was significantly different (17 vs. 3, P < 0.001). Lead age was similar with an average duration of 83 ± 87 months in CHD patients and 62 ± 65 months in controls (P = 0.24). There was no significant difference in extraction techniques. Manual traction was successful in 40% of CHD patients and 47% of controls, and advanced techniques were used in 60 and 53% of CHD patients and controls, respectively. Complete extraction was achieved in 94% of the patients in both groups. There was no significant difference in complications. Conclusion: Lead extraction can be safely performed in patients with CHD. Despite anatomic abnormalities and longer implantation times, the difficulty of lead extraction in patients with CHD is comparable with controls.

KW - Cardiac implantable electronic device

KW - Congenital heart disease

KW - Laser lead extraction

KW - Lead extraction

UR - http://www.scopus.com/inward/record.url?scp=85019748231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019748231&partnerID=8YFLogxK

U2 - 10.1093/europace/euw049

DO - 10.1093/europace/euw049

M3 - Article

C2 - 27738059

AN - SCOPUS:85019748231

VL - 19

SP - 441

EP - 446

JO - Europace

JF - Europace

SN - 1099-5129

IS - 3

ER -